Information Provided By:
Fly News Breaks for May 17, 2017
VIVO
May 17, 2017 | 09:50 EDT
Piper Jaffray analyst William Quirk expects "reputational damage" to Meridian Bioscience after the FDA issued a warning statement against using the company's Magellan LeadCare test systems citing the possibility of false negatives. It is possible Magellan revenue could fall by as much as 50% as physicians unplug systems, Quirk tells investors in a research note. He keeps an Underweight rating on shares of Meridian.
News For VIVO From the Last 2 Days
There are no results for your query VIVO